SCHEMBL8790494

SCHEMBL8790494

COC(=O)CC1CCNCC1.NC1CC1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.45
EPHX1 P07099 1/20 0.37
HTR4 Q13639 2/20 0.36
SLC6A1 P30531 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRB2 P47870 2/20 0.35
SLC6A12 P48065 2/20 0.35
SLC6A11 P48066 2/20 0.35
SLC6A13 Q9NSD5 2/20 0.35
GABRA1 P14867 1/20 0.35
GABRR1 P24046 1/20 0.35
GABRA4 P48169 1/20 0.35
GAA P10253 1/20 0.35
ANPEP P15144 1/20 0.35
ERAP2 Q6P179 1/20 0.35
ALOX15 P16050 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GNAI3 P08754 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL473986 0.87 EPHX1 (0.45) BRD4EPHX1HTR4SLC6A1GABRA5
Hydrochloric Acid SCHEMBL662153 0.85 EPHX1 (0.44) BRD4EPHX1SLC6A1GABRA5GABRB2
SCHEMBL8791493 0.80 SLC6A12 (0.56) EPHX1SLC6A1GABRA5GABRB2SLC6A12
SCHEMBL15054802 0.77 BRD4 (0.39) BRD4EPHX1SLC6A1GABRA5GABRB2
SCHEMBL15073379 0.77 BRD4 (0.39) BRD4EPHX1SLC6A1GABRA5GABRB2
SCHEMBL853499 0.76 SLC6A1 (0.60) BRD4EPHX1SLC6A1GABRA5GABRB2
SCHEMBL12571551 0.76 SLC6A1 (0.60) BRD4EPHX1SLC6A1GABRA5GABRB2
SCHEMBL12571547 0.76 SLC6A1 (0.60) BRD4EPHX1SLC6A1GABRA5GABRB2
SCHEMBL8791466 0.76 GLA (0.51) L3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL1966822 0.75 SLC6A1 (0.58) BRD4EPHX1SLC6A1GABRA5GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0800516-A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED (b)-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME NIPPON STEEL CORPORATION (JP) 1997-10-15 EP disclosed